ProSomnus Sleep Technologies

ProSomnus Sleep Technologies ProSomnus’s patient preferred devices are more comfortable, effective and less invasive than CPAP. To learn more, visit www.ProSomnus.com.

ProSomnus (NASDAQ: OSA) is a leading CPAP alternative for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each

patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government sponsored healthcare plans around the world, representing over 200 million covered lives.

Wrapped up an incredible couple of days at the 2026 American Academy of Dental Sleep Medicine (AADSM) Annual MeetingIt w...
05/03/2026

Wrapped up an incredible couple of days at the 2026 American Academy of Dental Sleep Medicine (AADSM) Annual Meeting

It was a truly energizing experience connecting with so many dedicated clinicians, partners, and innovators who are shaping the future of dental sleep medicine.

ProSomnus Sleep Technologies was proud to showcase Smart Sleep Medicine™ and highlight the recent FDA Class II clearance of the RPMO₂ OSA Device—bringing together precision therapy with multi-night physiologic monitoring, including SpO₂ and pulse rate.

Thank you to everyone who stopped by Booth #203, shared insights, and engaged in meaningful conversations about advancing patient-centric OSA care. We leave inspired, optimistic, and more committed than ever to driving innovation and improving outcomes for patients.

✨ Smart Sleep Medicine™ ✨

Fantastic Day at the 2026 American Academy of Dental Sleep Medicine Annual Meeting! 🚀Prosomnus Sleep Technologies excite...
05/01/2026

Fantastic Day at the 2026 American Academy of Dental Sleep Medicine Annual Meeting! 🚀

Prosomnus Sleep Technologies excited to be here, showcasing the future of Smart Sleep Medicine™ and connecting with customers, friends, and colleagues.

recently received FDA Class II clearance for the RPMO₂ OSA Device—the first oral appliance that combines precision therapy with multi-night physiologic monitoring, including SpO₂ and pulse rate.

Stop by Booth #203 to see how RPMO₂ is redefining data-driven, patient-centric OSA care.

✨ Smart Sleep Medicine™ ✨


Just one day to go until the 2026  American Academy of Dental Sleep Medicine Annual Meeting! 🚀ProSomnus Sleep Technologi...
04/30/2026

Just one day to go until the 2026 American Academy of Dental Sleep Medicine Annual Meeting! 🚀

ProSomnus Sleep Technologies is excited to be there, showcasing the future of Smart Sleep Medicine™ and connecting with customers, friends, and colleagues.

recently received FDA Class II clearance for the RPMO₂ OSA Device—the first oral appliance that combines precision therapy with multi-night physiologic monitoring, including SpO₂ and pulse rate.

Stop by Booth #203 to see how RPMO₂ is redefining data-driven, patient-centric OSA care.

✨ Smart Sleep Medicine™ ✨


ProSomnus Sleep Technologies RPMO₂ OSA Device provides objective oxygen data for OSA therapy—and transforms treatmentint...
04/29/2026

ProSomnus Sleep Technologies RPMO₂ OSA Device provides objective oxygen data for OSA therapy—and transforms treatment
into connected, measurable care.

The FDA-cleared RPMO₂ OSA Device by is the only medical device integrating OAT, oximetry, a smartphone app, and a provider portal. RPMO₂ helps bring oxygen insight into precision Oral Appliance Therapy—so sleep apnea care becomes more connected, personalized, and measurable. Better breathing at night 🌒 More meaningful moments by day☀️

Smart Sleep Medicine™

📩 Let’s connect: Info@ProSomnus.com

🔗Read the full press release here:
https://shorturl.at/50JrM

Counting down to the 2026 AADSM Annual Meeting!🚀ProSomnus Sleep Technologies is excited to be at the 2026 AADSM Annual M...
04/28/2026

Counting down to the 2026 AADSM Annual Meeting!🚀

ProSomnus Sleep Technologies is excited to be at the 2026 AADSM Annual Meeting showcasing the future of Smart Sleep Medicine™ and connect with our customers, friends, colleagues. Nothing beats getting together in person to share ideas, learn, and build what’s next. See you soon!

recently received FDA Class II clearance for the RPMO₂ OSA Device—the first theragnostic oral appliance that combines precision therapy with multi-night physiologic monitoring, including SpO₂ and pulse rate.

Stop by Booth #203 to see how RPMO₂ is redefining data-driven, patient-centric OSA care.

Smart Sleep Medicine™

04/24/2026

"Clinicians can now pair precision OAT with continuous physiologic monitoring through the RPMO₂ OSA Device, enabling data‑driven adjustments while overcoming the limits of single‑night testing, and bringing sleep apnea care into a modern chronic disease model."
—Edward Sall, MD, DDS

ProSomnus.com | ProSomnus Sleep Technologies

ProSomnus Sleep Technologies RPMO₂ OSA Device helps take the guesswork out of sleep by measuring what matters most—oxyge...
04/20/2026

ProSomnus Sleep Technologies RPMO₂ OSA Device helps take the guesswork out of sleep by measuring what matters most—oxygen.

The FDA-cleared RPMO₂ OSA Device by , is the only medical device integrating OAT, oximetry, a smartphone app, and a provider portal. RPMO₂ helps bring oxygen insight into precision Oral Appliance Therapy—so sleep apnea care becomes more connected, personalized, and measurable. Because better nights should lead to brighter mornings.

✨ Smart Sleep Medicine™ ✨

📩 Let’s connect: Info@ProSomnus.com

🔗Read the full press release here:
https://lnkd.in/gxu8za3d

04/13/2026

📣 ProSomnus Sleep Technologies Receives FDA Class II Clearance for RPMO2 OSA Device 📣

The ProSomnus RPMO2 OSA Device is the first theragnostic device for sleep medicine, incorporating both precision oral appliance therapy and multi-night physiologic monitoring in one device.

“The FDA’s clearance of the RPMO₂ OSA Device marks a significant milestone for sleep medicine,” stated Len Liptak, Chief Executive Officer of ProSomnus. “By integrating safe, accurate, continuous physiologic measurement into our precision oral appliance platform, we are enabling Smart Sleep Medicine—a connected, data driven model that helps clinicians manage sleep apnea as the personal, individualized and chronic disease it truly is.”

🔗Read the full press release here:
https://shorturl.at/SXD7e

✨Smart Sleep Medicine™ ✨

Better Sleep Touches Every Part of Life.😊😊When more than 10,000 patients and providers share their experience, the messa...
04/07/2026

Better Sleep Touches Every Part of Life.😊😊

When more than 10,000 patients and providers share their experience, the message is unmistakable: ProSomnus Sleep Technologies Devices deliver 99% satisfaction. That’s consistency, compliance, and clinical confidence—at scale.

Engineered with precision and built for real-world performance, ProSomnus delivers reliable outcomes across diverse patient populations. The result? Measurable improvement—trusted by clinicians and appreciated by patients.
🌙 The Leading non-CPAP OSA Therapy®

📩 Let’s connect: Info@ProSomnus.com
†ProSomnus company data on file

04/01/2026

"The ProSomnus EVO Guided oral device provides more tongue space, allowing for faster titration to that optimal sweet spot. Patients also appreciate its slimmer, more comfortable design."
—Charles Tozzer, DDS Sleep Apnea Centers of California

Prosomnus.com | ProSomnus Sleep Technologies

🎓 Don't miss a live introduction to Patient Engagement with ProSomnus HWO₂ April 14, 2026 / 5:00 PM PT (US and Canada) J...
03/27/2026

🎓 Don't miss a live introduction to Patient Engagement with ProSomnus HWO₂

April 14, 2026 / 5:00 PM PT (US and Canada)

Join us for this practical webinar discussing success stories for the ProSomnus Sleep TechnologiesBuccal Mucosal Oximeter Device. Panelists will break down exactly how everyday practices are positioning HWO₂ as a valuable upgrade that patients understand, appreciate, and invest in. You’ll learn how to confidently introduce HWO₂, create clear value for patients, and implement realistic medical billing and reimbursement pathways.

👉 LEARN MORE & REGISTER TODAY
https://us02web.zoom.us/webinar/register/WN_X_0jHxg1StOBo9XmbLOXrg

Hosted by ProSomnus Sleep Technologies

✨ The Leading non-CPAP OSA Therapy® ✨

03/25/2026

±1 mm Accuracy 🎯
Only Sleep Devices are designed to achieve precision at this level.

Research demonstrates that the accuracy of a precision manufactured device can improve airway collapsibility, muscle function, and treatment outcomes. ProSomnus Sleep Technologies Devices are engineered to ±1 mm accuracy—supporting precise titration designed to optimize efficacy while minimizing unnecessary advancement.

✨ The leading non-CPAP OSA therapy® ✨

Address

5675 Gibraltar Drive
Pleasanton, CA
94588

Opening Hours

Monday 6am - 5pm
Tuesday 6am - 5pm
Wednesday 6am - 5pm
Thursday 6am - 5pm
Friday 6am - 5pm

Telephone

+18445375337

Alerts

Be the first to know and let us send you an email when ProSomnus Sleep Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ProSomnus Sleep Technologies:

Share